Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

IU School of Medicine and partners receive funding to deploy collaborative dementia care model

Supported by a $1.3 million grant from the U.S. Administration for Community Living, Department of Health and Human Services, Indiana University School of Medicine and its partners have launched a 36-month venture to enhance, strengthen and expand supports for people with Alzheimer's Disease and Related Dementias (ADRD) and their caregivers in 34 Indiana counties.

14 Sep 2020

Drug for liver cirrhosis shows potential to treat dementia and motor neuron disease

A drug used to treat cirrhosis of the liver may be an effective treatment for a form of Dementia and motorneuron disease, scientists have discovered.

14 Sep 2020

NIH provides additional support for large scale study of Alzheimer's disease biomarkers

To meet the pressing need to better understand the prevalence, progression, and clinical impact of Alzheimer's disease among Mexican Americans, the National Institutes of Health has added funding for more biomarker measures, including positron emission tomography imaging, to the ongoing Health and Aging Brain Among Latino Elders Study.

14 Sep 2020

MSU engineers secure $3.4 million to develop diamond devices to detect Parkinson's

Engineers from Michigan State University have secured $3.4 million in grants to develop diamond implants that could let doctors diagnose and treat Parkinson's disease earlier.

12 Sep 2020

Even mild concussions cause severe and long-lasting impairments in the brain

Even mild concussions cause severe and long-lasting impairments in the brain's ability to clean itself of toxins, and this may seed it for Alzheimer's disease, dementia and other neurodegenerative problems, new research from the University of Virginia School of Medicine reveals.

11 Sep 2020

Lifestyle-based changes may modify the course of cognitive decline

Results from a new study suggest that lifestyle changes may help to improve cognition in older adults experiencing cognitive decline that precedes dementia.

10 Sep 2020

Hospitals, nursing homes fail to separate COVID patients, putting others at risk

Nurses at Alta Bates Summit Medical Center were on edge as early as March when patients with COVID-19 began to show up in areas of the hospital that were not set aside to care for them.

10 Sep 2020

Researchers receive $16 million NIH grant to study link between autophagy and Alzheimer's disease

Age is the most significant risk factor for Alzheimer's disease. In the United States, approximately 1 in 10 people over the age of 65 have the disease, and the odds increase to nearly 1 in 3 for those over 85. However, the mechanisms by which aging increases risk are unknown.

9 Sep 2020

Alcohol-induced vitamin B1 deficiency can be a key factor in cognitive decline

A common consequence of chronically high alcohol consumption is a decline in cognitive function, which can even progress to full-blown dementia. However, we do not yet fully understand how alcohol damages the brain.

9 Sep 2020

Protein aggregation reduces elasticity of blood vessels in the brain

Deposits of a protein called "Medin", which manifest in virtually all older adults, reduce the elasticity of blood vessels during aging and hence may be a risk factor for vascular dementia.

9 Sep 2020

Researchers discuss the role of chemical senses in disease and social interactions in humans, animals

Across 5 days in August (3rd-7th), scientists from around the world gathered virtually to present and discuss new information on the role of the chemical senses in disease, nutrition, and social interactions in humans and animals.

9 Sep 2020

Research finds different patterns of blood use in the brains of older women with Type 2 diabetes

A University of Houston researcher is reporting that the brains of older women with Type 2 diabetes do not use as much oxygenated blood as those who don't have the disease.

8 Sep 2020

Investigational drug may reduce protein buildup and neurological decline linked to ALS, FTD

An investigational drug that targets an instigator of the TDP-43 protein, a well-known hallmark of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), may reduce the protein's buildup and neurological decline associated with these disorders, suggests a pre-clinical study from researchers at Penn Medicine and Mayo Clinic.

8 Sep 2020

American Heart Association honors UVA professor for contributions to cardiovascular research

Robert M. Carey, MD, Professor of Medicine at the University of Virginia School of Medicine, has been named a Distinguished Scientist of the American Heart Association for his "extraordinary contributions" to cardiovascular research.

8 Sep 2020

Microglia-targeting nanotherapeutics for treatment of neurodegenerative disorders

Inspired by the need for new and better therapies for neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, Rutgers University researchers are exploring the link between uncontrolled inflammation within the brain and the brain's immune cells, known as microglia.

8 Sep 2020

New insights into how the brain can induce diabetes remission in rodents

In rodents with type 2 diabetes, a single surgical injection of a protein called fibroblast growth factor 1 can restore blood sugar levels to normal for weeks or months. Yet how this growth factor acts in the brain to generate this lasting benefit has been poorly understood.

7 Sep 2020

A potential new way of treating Alzheimer’s Disease

In this interview, Dr. Brad. L. Heckman speaks to News-Medical about a new pathway that could potentially treat Alzheimers disease.

7 Sep 2020

MIS-C linked to COVID-19 damages children's hearts

Multisystem inflammatory syndrome in children (MIS-C), believed to be linked to COVID-19, damages the heart to such an extent that some children will need lifelong monitoring and interventions, said the senior author of a medical literature review published Sept. 4 in EClinicalMedicine, a journal of The Lancet.

5 Sep 2020

Common class of drugs may be associated with increased risk of cognitive decline

A team of scientists, led by researchers at University of California San Diego School of Medicine, report that a class of drugs used for a broad array of conditions, from allergies and colds to hypertension and urinary incontinence, may be associated with an increased risk of cognitive decline, particularly in older adults at greater risk for Alzheimer's disease.

5 Sep 2020

Army-funded study explores the effects of sleep deprivation in soldiers

New Army-funded study looks at effects of sleep deprivation, which can greatly affect Soldiers on the battlefield.

3 Sep 2020

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

IU School of Medicine and partners receive funding to deploy collaborative dementia care model

Drug for liver cirrhosis shows potential to treat dementia and motor neuron disease

NIH provides additional support for large scale study of Alzheimer's disease biomarkers

MSU engineers secure $3.4 million to develop diamond devices to detect Parkinson's

Even mild concussions cause severe and long-lasting impairments in the brain

Lifestyle-based changes may modify the course of cognitive decline

Hospitals, nursing homes fail to separate COVID patients, putting others at risk

Researchers receive $16 million NIH grant to study link between autophagy and Alzheimer's disease

Alcohol-induced vitamin B1 deficiency can be a key factor in cognitive decline

Protein aggregation reduces elasticity of blood vessels in the brain

Researchers discuss the role of chemical senses in disease and social interactions in humans, animals

Research finds different patterns of blood use in the brains of older women with Type 2 diabetes

Investigational drug may reduce protein buildup and neurological decline linked to ALS, FTD

American Heart Association honors UVA professor for contributions to cardiovascular research

Microglia-targeting nanotherapeutics for treatment of neurodegenerative disorders

New insights into how the brain can induce diabetes remission in rodents

A potential new way of treating Alzheimer’s Disease

MIS-C linked to COVID-19 damages children's hearts

Common class of drugs may be associated with increased risk of cognitive decline

Army-funded study explores the effects of sleep deprivation in soldiers

Discovering a molecule that could replicate SARS-CoV-2

Providing Personalized Care for Bleeding Disorders

Delayed immune responses may be responsible for COVID-19 mortality rates

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Newsletters you may be interested in